The Global Cell Cryopreservation Market Growth Accelerated By Increased R&D In Stem Cell Therapies

Cell cryopreservation refers to the process of cell freezing and storage at very low temperature. Cells from an organ, tissue or blood can be cryopreserved for long periods of time. Stem cell therapies have the potential to treat cancer, heart disease, diabetes and other conditions. Extensive R&D is ongoing to develop new stem cell therapies. Umbilical cord blood containing stem cells of newborns is also increasingly being cryopreserved for future therapeutic use if needed.

The global Cell Cryopreservation Market is estimated to be valued at US$ 228.8 Mn in 2023 and is expected to exhibit a CAGR of 5.7%  over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The increased R&D in stem cell therapies is a key trend driving growth of the cell cryopreservation market. Researchers are developing new therapies using stem cells sourced from umbilical cord blood, bone marrow, adipose tissue etc. To facilitate future clinical usage of these stem cells, large numbers are being cryopreserved. This is resulting in rising demand for specialized equipment, media and cryovials for cell freezing and long term storage. Further, private stem cell banks are also emerging which store umbilical cord blood stem cells for individuals as a preventive healthcare measure. This is positively impacting the cell cryopreservation market.

Segment Analysis
The global cell cryopreservation market is dominated by the stem cell banking segment. Stem cell banking involves cryopreservation of stem cells sourced from cord blood, bone marrow, adipose tissue etc. for future therapeutic use. It dominates as storing one's own stem cells or that of family members allows accessibility to life-saving treatments if needed in future without dependence on unrelated donors. It has wide applications across diseases like cancer, blood disorders.

Key Takeaways
The global Cell Cryopreservation Market Demand is expected to witness high growth over the forecast period. The global Cell Cryopreservation Market is estimated to be valued at US$ 228.8 Mn in 2023 and is expected to exhibit a CAGR of 5.7%  over the forecast period 2023 to 2030.

North America dominated market in 2024 with a share of over 35% attributed to well-established healthcare infrastructure, growing stem cell research activities in the US and Canada. Asia Pacific is expected to be the fastest growing region owing to increasing healthcare expenditure, rising medical tourism in countries like India and China.

Key players operating in the cell cryopreservation market are BASF, DSM, Kemin Industries, Naturex, Synthite Industries. BASF is a leading company in cell cryopreservation solutions offering freeze media, equipment for controlled rate freezing protocols. It caters to stem cell banks, biobanks, research organizations. DSM provides specialized solutions for adipose tissue banking while Kemin focuses on cryopreservation of platelets, red blood cells.

Explore more related article on this topic: https://www.ukwebwire.com/demand-for-cell-preservation-is-driving-the-cell-cryopreservation-market/